Clinical Trial

A Study on the Live-Attenuated Herpes Zoster Vaccine for Sequential Booster Immunization Following Recombinant Herpes Zoster Vaccine

Name: A Study on the Live-Attenuated Herpes Zoster Vaccine for Sequential Booster Immunization Following Recombinant Herpes Zoster Vaccine — clinical trial record (NCT07753265)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Early Phase 1

View on ClinicalTrials.gov →

Summary

Evaluate the immunogenicity after boost vaccination with the live attenuated herpes zoster vaccine.

Trial Details

NCT Number	NCT07753265
Lead Sponsor	Changchun BCHT Biotechnology Co.
Conditions	Herpse Zoster
Enrollment	100 participants
Start Date	2026-08-13
Primary Completion	2026-09-20 (estimated)
Study Completion	2026-09-20 (estimated)
Updated on ClinicalTrials.gov	2026-08-07